Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

c-Myb promotes the survival of CD4+CD8+ double-positive thymocytes through upregulation of Bcl-xL.

Yuan J, Crittenden RB, Bender TP.

J Immunol. 2010 Mar 15;184(6):2793-804. doi: 10.4049/jimmunol.0902846. Epub 2010 Feb 8.

2.
3.

The transcription factor c-Myb primes CD4+CD8+ immature thymocytes for selection into the iNKT lineage.

Hu T, Simmons A, Yuan J, Bender TP, Alberola-Ila J.

Nat Immunol. 2010 May;11(5):435-41. doi: 10.1038/ni.1865. Epub 2010 Apr 11.

5.

Functional and molecular analysis of the double-positive stage-specific CD8 enhancer E8III during thymocyte development.

Feik N, Bilic I, Tinhofer J, Unger B, Littman DR, Ellmeier W.

J Immunol. 2005 Feb 1;174(3):1513-24.

6.

Critical functions for c-Myb at three checkpoints during thymocyte development.

Bender TP, Kremer CS, Kraus M, Buch T, Rajewsky K.

Nat Immunol. 2004 Jul;5(7):721-9. Epub 2004 Jun 13.

PMID:
15195090
7.

Regulation of Bim by TCR signals in CD4/CD8 double-positive thymocytes.

Bunin A, Khwaja FW, Kersh GJ.

J Immunol. 2005 Aug 1;175(3):1532-9.

8.

Role of CTLA-4 in the activation of single- and double-positive thymocytes.

Kwon H, Jun HS, Khil LY, Yoon JW.

J Immunol. 2004 Dec 1;173(11):6645-53.

9.

BCL-XL-regulated apoptosis in T cell development.

Chao DT, Korsmeyer SJ.

Int Immunol. 1997 Sep;9(9):1375-84.

10.

Stabilized beta-catenin extends thymocyte survival by up-regulating Bcl-xL.

Xie H, Huang Z, Sadim MS, Sun Z.

J Immunol. 2005 Dec 15;175(12):7981-8.

11.

Absence of programmed death receptor 1 alters thymic development and enhances generation of CD4/CD8 double-negative TCR-transgenic T cells.

Blank C, Brown I, Marks R, Nishimura H, Honjo T, Gajewski TF.

J Immunol. 2003 Nov 1;171(9):4574-81.

12.

Protein kinase C-theta-mediated signals enhance CD4+ T cell survival by up-regulating Bcl-xL.

Manicassamy S, Gupta S, Huang Z, Sun Z.

J Immunol. 2006 Jun 1;176(11):6709-16.

13.
14.

T cell factor 1 regulates thymocyte survival via a RORγt-dependent pathway.

Wang R, Xie H, Huang Z, Ma J, Fang X, Ding Y, Sun Z.

J Immunol. 2011 Dec 1;187(11):5964-73. doi: 10.4049/jimmunol.1101205. Epub 2011 Oct 28.

15.

MEK activity regulates negative selection of immature CD4+CD8+ thymocytes.

Bommhardt U, Scheuring Y, Bickel C, Zamoyska R, Hünig T.

J Immunol. 2000 Mar 1;164(5):2326-37.

16.

Runx3 regulates integrin alpha E/CD103 and CD4 expression during development of CD4-/CD8+ T cells.

Grueter B, Petter M, Egawa T, Laule-Kilian K, Aldrian CJ, Wuerch A, Ludwig Y, Fukuyama H, Wardemann H, Waldschuetz R, Möröy T, Taniuchi I, Steimle V, Littman DR, Ehlers M.

J Immunol. 2005 Aug 1;175(3):1694-705. Erratum in: J Immunol. 2005 Nov 1;175(9):6238.

18.

The role of the Ets2 transcription factor in the proliferation, maturation, and survival of mouse thymocytes.

Zaldumbide A, Carlotti F, Pognonec P, Boulukos KE.

J Immunol. 2002 Nov 1;169(9):4873-81.

19.

Human CD4 expression at the late single-positive stage of thymic development supports T cell maturation and peripheral export in CD4-deficient mice.

Boyer O, Marodon G, Cohen JL, Lejeune L, Irinopoulou T, Liblau R, Bruneval P, Klatzmann D.

J Immunol. 2002 Oct 15;169(8):4347-53.

20.

Reduction of Runx1 transcription factor activity up-regulates Fas and Bim expression and enhances the apoptotic sensitivity of double positive thymocytes.

Abe N, Kohu K, Ohmori H, Hayashi K, Watanabe T, Hozumi K, Sato T, Habu S, Satake M.

J Immunol. 2005 Oct 1;175(7):4475-82.

Items per page

Supplemental Content

Write to the Help Desk